Design, synthesis, and biological evaluation of piperidinyl‐substituted [1,2,4]triazolo[1,5‐a]pyrimidine derivatives as potential anti‐HIV‐1 agents with reduced cytotoxicity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, synthesis, and biological evaluation of piperidinyl‐substituted [1,2,4]triazolo[1,5‐a]pyrimidine derivatives as potential anti‐HIV‐1 agents with reduced cytotoxicity
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-29
DOI
10.1111/cbdd.13760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties
- (2019) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
- (2019) Boshi Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities
- (2019) Ting Xiao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles
- (2019) Yali Sang et al. JOURNAL OF MEDICINAL CHEMISTRY
- First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain
- (2018) Boshi Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel”
- (2018) Zhongxia Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors
- (2018) Shuang-Xi Gu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBP
- (2017) Dongwei Kang et al. ACS Medicinal Chemistry Letters
- Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles
- (2016) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
- (2016) Na Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dithiocarbamate–thiourea hybrids useful as vaginal microbicides also show reverse transcriptase inhibition: Design, synthesis, docking and pharmacokinetic studies
- (2015) Veenu Bala et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches
- (2015) Boshi Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: Design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines
- (2015) Boshi Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1
- (2015) Boshi Huang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
- (2015) Peng Zhan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ten Paths to the Discovery of Antivirally Active Nucleoside and Nucleotide Analogues
- (2012) Erik De Clercq NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
- (2011) Peng Zhan et al. MEDICINAL RESEARCH REVIEWS
- Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Benzyl derivatives with broad potency against resistant mutant viruses
- (2010) Denis J. Kertesz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Physicochemical Properties of the Amorphous Drug, Cast Films, and Spray Dried Powders to Predict Formulation Probability of Success for Solid Dispersions: Etravirine
- (2010) Ilse Weuts et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later
- (2008) Christophe Pannecouque et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started